💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @newsfilterio | 9 |
| @Tickeron | 8 |
| @sleekoptions | 6 |
| @MarcJacksonLA | 5 |
| @TradeWithAlerts | 5 |
Recent Tweets for INCY
 |
@sleekoptions $INCY Was up 1.26 %. Turned negative -0.01% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/xgQfS3N7CR 2:04am |
 |
@newsfilterio Incyte and Morphosys dose first patient in late-stage lymphoma study $INCY $MOR https://t.co/4IdM9PQlnY 12:04am |
 |
@Briefingcom $INCY: Incyte and MorphoSys AG (MOR) announce that the first patient has been dosed in the placebo-controlled Phase… https://t.co/2mjdQJfFTL April 19th 2021, 10:04pm |
 |
@otcdynamics $INCY Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasita… https://t.co/VQ6cN566o1 April 19th 2021, 8:04pm |
 |
@MarcJacksonLA $INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/SbiY8fxM54 April 19th 2021, 8:04pm |
 |
@biotechradar_eu Incyte $INCY and MorphoSys $MOR Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/w5LbW4oenj April 19th 2021, 8:04pm |
 |
@stock_titan $INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Taf… https://t.co/7pNixbP8fb April 19th 2021, 8:04pm |
|
@sleekoptions $INCY Was up 1.26 %. Turned negative -0.51% | (Green to red move) #GreenToRed https://t.co/GVxlCvYL4r https://t.co/r785sEUfh1 April 19th 2021, 3:04pm |
|
@MarcJacksonLA $INCY Buy or Fear Incyte’s Stock: INCY’s 17% Decline In A Year Despite Revenues Increasing 17% YoY Over The Last 4… https://t.co/XZITjzGbfp April 19th 2021, 2:04pm |
 |
@mediasentiment $INCY new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 190 April 18th 2021, 9:04pm |
 |
@Tickeron $INCY in Downtrend: its price may drop because broke its higher Bollinger Band on April 1, 2021. View odds for this… https://t.co/M6NeVOV2B4 April 18th 2021, 9:04pm |
 |
@communiststocks Incyte - $INCY ? QUOTE $INCY was DOWN ? on Fri Apr 16 Closed at 82.68 USD for a -0.62% loss from previous close ?… https://t.co/sTx99j9KXK April 18th 2021, 8:04am |
 |
@ms101phd $LLY $INCY Eli Lilly and Incyte was another overhyped and rushed phase 3 antiviral trial failure with Baricitinib.… https://t.co/w2L1zVxE4F April 17th 2021, 2:04pm |
 |
@optioncharts $INCY open interest for maturity 05/21/2021. High put=80.00 High call=85.00 PutCallRatio=0.30 #maxpain #options… https://t.co/m4GXbJ41EA April 17th 2021, 1:04pm |
 |
@PorqueNoTrade $INCY With $LLY, aricitinib fails to meet main goal in late-stage COVID-19 trial #Stocks #Trading #TradingNews #StockMarketNews #PQNews April 17th 2021, 9:04am |
|
@newsfilterio Incyte: What Falling Off A Cliff Looks Like $INCY https://t.co/pqhRaaKTJ6 April 17th 2021, 6:04am |
 |
@QuantData Incyte Corp Trial Did Not Meet Statistical Significance On Primary Endpoint Related Tickers: $INCY Read more at: https://t.co/Z7qrfq34mm April 16th 2021, 8:04pm |
|
@newsfilterio Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial $LLY $INCY https://t.co/6cNyVOuqiM April 16th 2021, 8:04pm |
 |
@Globalmess65 $INCY trial did not meet end point April 16th 2021, 8:04pm |
|
@Tickeron $INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/QYdeVQJrVn April 16th 2021, 8:04pm |
 |
@StckPro $INCY NEW ARTICLE : Incyte: What Falling Off A (Patent) Cliff Looks Like https://t.co/TCHNd4q0AO Get all the latest… https://t.co/8PERy0eS97 April 16th 2021, 1:04pm |
 |
@SeekingAlpha $INCY - Incyte: What Falling Off A (Patent) Cliff Looks Like. https://t.co/rlAf3BlMHC #trading #economy #finance April 16th 2021, 1:04pm |
 |
@SwingTradeBot Recent $INCY technical alerts: MACD Bullish Centerline Cross plus 7 more alerts... https://t.co/w5vDMJe2Lv April 16th 2021, 1:04pm |
 |
@StockTexts $INCY Incyte Corporation SEC Filing: Form DEF 14A https://t.co/gf3YyQXWnu April 16th 2021, 12:04pm |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in INCYTE $INCY https://t.co/wfb6FB7BrL April 16th 2021, 12:04pm |
 |
@FlashAlert_me $INCY [15s. delayed] filed form DEFA14A on April 16, 08:16:29 https://t.co/u0ms53rIl1 April 16th 2021, 12:04pm |
|
@FlashAlert_me $INCY [15s. delayed] filed form DEF 14A on April 16, 08:15:23 https://t.co/DRrRu9aavJ April 16th 2021, 12:04pm |
 |
@fintel_io $INCY / Incyte files form DEF 14A https://t.co/Oc4NyYycjO April 16th 2021, 12:04pm |
|
@Tickeron $INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/XApO2SezHB April 15th 2021, 9:04pm |
 |
@CarlosCarloan @unusual_whales He did this with $INCY, touted it in the 140s, hasn’t sniffed that number in the 4 years since. April 15th 2021, 2:04am |
 |
@TradeWithAlerts Large Print $INCY Size: 148890 Price: 82.21 Time: 1600 Amount: $12,240,246.90 April 14th 2021, 8:04pm |
|
@optioncharts $INCY high OI range is 80.00 to 87.50 for option expiration 04/16/2021 PutCallRatio=0.38 #maxpain #options… https://t.co/QLzpWrlg33 April 14th 2021, 10:04am |
|
@newsfilterio Incyte to Report First Quarter Financial Results $INCY https://t.co/niy9kzmuNb April 14th 2021, 5:04am |
 |
@savage_swings $INCY #Earnings 5/3 At trend line support. https://t.co/XyMJs25TyC April 13th 2021, 11:04pm |
 |
@InsiderAlerts4U $INCY: New Insider Filing on INCYTE CORP's EVP & General Counsel MARIA E PASQUALE: https://t.co/tmYOzRgLpl April 13th 2021, 8:04pm |
|
@FlashAlert_me $INCY [15s. delayed] filed SEC form 4: EVP & General Counsel Pasquale Maria E: Delivered securities 517 of Common… https://t.co/g4tSrqT56q April 13th 2021, 8:04pm |
|
@TradeWithAlerts Large Print $INCY Size: 261020 Price: 80.65 Time: 1600 Amount: $21,051,263.00 April 13th 2021, 8:04pm |
 |
@equity_newswire $INCY Incyte to Report First Quarter Financial Results https://t.co/2djeO7tkg7 April 13th 2021, 6:04pm |
 |
@A1Syad $INCY // Signals could not be any clearer on the 5-minute chart of INCY!!.. https://t.co/z0NXYn9tOs April 13th 2021, 6:04pm |
|
@Tickeron $INCY in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators:… https://t.co/TacPJwhTO1 April 13th 2021, 3:04pm |
|
@FlashAlert_me $INCY [15s. delayed]: Issued Press Release on April 13, 08:00:00: Incyte to Report First Quarter Financial Results https://t.co/9BLhWdw8Xi April 13th 2021, 12:04pm |
|
@stock_titan $INCY Incyte to Report First Quarter Financial Results https://t.co/2NWOB5vbBr April 13th 2021, 12:04pm |
|
@SeekingAlpha $INCY - Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow. https://t.co/0UtBMJrqFu #business #stockmarket #finance April 12th 2021, 7:04pm |
 |
@Gambiste1 RT @OptionsLeague: $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/6W9tTReOLX credit: @WallStJesus April 12th 2021, 5:04pm |
 |
@OptionsLeague $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/6W9tTReOLX credit: @WallStJesus April 12th 2021, 4:04pm |
 |
@sole_nyc23 RT @WallStJesus: $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/gNrK6ugtds April 12th 2021, 4:04pm |
 |
@WallStJesus $INCY Update from AACR on the adenosine programs; Reiterate BUY https://t.co/gNrK6ugtds April 12th 2021, 4:04pm |
|
@optioncharts $INCY Implied Volatility expiration 04/16/2021 #maxpain #options https://t.co/PJHtr5kpDR https://t.co/AzyxblTyhQ April 12th 2021, 12:04pm |
 |
@TVMoneymakero $INCY chart https://t.co/SvowrR3Ao5 via https://t.co/CoKk1OcPOi April 12th 2021, 4:04am |
|
@Tickeron $INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators:… https://t.co/XSdckBH40H April 11th 2021, 10:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
